课题基金 / 基金详情

Vaccination Against Ixodes scapularis Tick Bites

Vaccination Against Ixodes scapularis Tick Bites
肩胛硬蜱蜱叮咬疫苗接种
批准号:
6337782
负责人:
Raymond Allen Koski
金额:
$9.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-15 至 2002-08-31

项目摘要

项目成果

Raymond Allen Koski的其他基金

相似基金

相关文献

中文摘要
翻译
莱姆病是由伯氏疏螺旋体引起的多系统感染。黑腿蜱,肩胛骨蜱,是伯氏疏螺旋体的常见媒介。这个项目的目的是开发一种抗i。阻断蜱附着及蜱媒疾病传播的肩胛骨疫苗。感染了肩胛绦虫的兔子或豚鼠会获得抗体介导的对蜱虫叮咬的抵抗力,这种现象被称为“蜱虫免疫”。我们开发了一种豚鼠宿主对蜱虫免疫的模型。蜱致敏的豚鼠在被伯氏疏螺旋体感染时不患莱姆病。scapularis。我们的计划是确定哪种蜱唾液腺抗原赋予这种宿主免疫力,然后将其作为重组抗原生产出来,作为候选疫苗进行评估。在初步实验中,从肩胛骨鼠唾液腺cdna中表达的两个重组蛋白Salp13和Salp25D诱导蜱免疫。第一阶段的研究将在原核和真核I表达系统中产生重组蛋白。将用纯化抗原对豚鼠和家兔进行免疫。然后,我们将展示宿主对蜱虫的抵抗力,以及对受感染蜱虫传播伯氏疏螺旋体的抑制。这些实验将导致新疫苗的第二阶段开发,以防止多种蜱传病原体。拟议的商业应用:一种针对肩胛硬体蜱叮咬的疫苗可能会预防几种病原体,包括伯氏疏螺旋体(人粒细胞埃利希体病的病原体)和微小巴贝斯虫。商业市场将与莱姆病疫苗LYMErix的市场重叠,这是一种由SmithKline Beecham成功销售的莱姆病疫苗。
英文摘要
Lyme disease is a multi-systemic infection and is caused by the pathogen Borrelia burgdorferi. The blacklegged tick, Ixodes scapularis, is the common vector for B. burgdorferi. The purpose of this project is to develop an anti-I. scapularis vaccine to block tick attachment and tick-mediated disease transmission. . Rabbits or guinea pigs infested with I. scapularis acquire antibody- mediated resistance to tick bites, a phenomenon known as "tick- immunity." We have developed a guinea pig model of host immunity against ticks. The tick-sensitized guinea pigs do not acquire Lyme disease when challenged with B. burgdorferi-infected I.. scapularis. Our plan is to determine which tick salivary gland antigens confer such host immunity, and subsequently produce them as recombinant antigens for evaluation as candidate vaccines. In preliminary experiments two recombinant proteins expressed from I. scapularis salivary gland cDNAs, Salp13 and Salp25D, induced tick-immunity. Phase I research will produce the recombinant proteins in prokaryotic and eukaryotic I expression systems. Guinea pigs and rabbits will be immunized with the purified antigens. We will then demonstrate host resistance to ticks, and inhibition of B. burgdorferi transmission from infected ticks. These experiments will lead to Phase II development of new vaccines to protect against multiple tick-borne pathogens. PROPOSED COMMERCIAL APPLICATIONS: A vaccine against Ixodes scapularis tick bites would potentially protect against several pathogens, including B. burgdorferi, the agent of human granulocytic ehrlichiosis, and Babesia microti. The commercial market would overlap with the market for LYMErix, a Lyme disease vaccine successfully sold by SmithKline Beecham.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Protection Against West Nile Virus by RNA Interference
  • 批准号:
    6882929
  • 项目类别:
  • 资助金额:
    $35.19万
  • 财政年份:
    2005
  • 负责人:
    Raymond Allen Koski
  • 依托单位:
Protection Against West Nile Virus by RNA Interference
  • 批准号:
    7058268
  • 项目类别:
  • 资助金额:
    $36.18万
  • 财政年份:
    2005
  • 负责人:
    Raymond Allen Koski
  • 依托单位:
Antibody Prophylaxis and Therapy of Flavivirus Infection
  • 批准号:
    6890457
  • 项目类别:
  • 资助金额:
    $46.96万
  • 财政年份:
    2004
  • 负责人:
    Raymond Allen Koski
  • 依托单位:
Recombinant Subunit West Nile Virus Vaccine Development
  • 批准号:
    6942279
  • 项目类别:
  • 资助金额:
    $167.3万
  • 财政年份:
    2004
  • 负责人:
    Raymond Allen Koski
  • 依托单位:
海外基金